Redcare Pharmacy NV Stock

Equities

RDC

NL0012044747

Drug Retailers

Real-time Estimate Tradegate 03:56:54 2024-06-10 am EDT 5-day change 1st Jan Change
114.8 EUR -1.67% Intraday chart for Redcare Pharmacy NV -2.63% -12.92%
Sales 2024 * 2.39B 2.57B Sales 2025 * 2.92B 3.14B Capitalization 2.37B 2.55B
Net income 2024 * -7M -7.53M Net income 2025 * 41M 44.08M EV / Sales 2024 * 1.06 x
Net Debt 2024 * 162M 174M Net Debt 2025 * 143M 154M EV / Sales 2025 * 0.86 x
P/E ratio 2024 *
-318 x
P/E ratio 2025 *
64.6 x
Employees 1,900
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.87%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.09%
1 week+1.92%
Current month+1.92%
1 month-7.01%
3 months-3.47%
6 months-12.39%
Current year-11.32%
More quotes
1 week
113.70
Extreme 113.7
119.00
1 month
95.60
Extreme 95.6
124.10
Current year
95.60
Extreme 95.6
153.00
1 year
85.72
Extreme 85.72
153.00
3 years
36.51
Extreme 36.51
182.00
5 years
28.30
Extreme 28.3
249.00
10 years
24.00
Extreme 24
249.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 23-07-31
Director of Finance/CFO 51 20-01-31
Chief Operating Officer - -
Members of the board TitleAgeSince
Chairman 52 15-12-31
Founder 60 00-12-31
Director/Board Member 53 22-04-13
More insiders
Date Price Change Volume
24-06-10 114.6 -1.80% 3 243
24-06-07 116.7 -0.43% 60,107
24-06-06 117.2 +0.69% 55,131
24-06-05 116.4 +1.84% 54,188
24-06-04 114.3 -2.89% 61,462

Delayed Quote Xetra, June 07, 2024 at 11:35 am EDT

More quotes
Redcare Pharmacy NV is a company based in the Netherlands that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
116.7 EUR
Average target price
149.4 EUR
Spread / Average Target
+28.03%
Consensus